Takeda Unit Warns Fed. Circ. Antibody Patents At Risk

By Dani Kass · June 13, 2022, 9:05 PM EDT

Baxalta Inc. has urged the Federal Circuit to revive an antibody patent invalidated by Circuit Judge Timothy Dyk while sitting in Delaware, saying the ruling wrongly declares the field of antibodies...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Baxalta Incorporated v. Genentech, Inc.

Case Number

22-1461

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Qst.)

Date Filed

February 10, 2022